Cargando…
Managing abnormal liver tests in children with inflammatory bowel disease
PURPOSE OF REVIEW: Liver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental findin...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452316/ https://www.ncbi.nlm.nih.gov/pubmed/34261897 http://dx.doi.org/10.1097/MOP.0000000000001045 |
_version_ | 1784570041443811328 |
---|---|
author | van Rheenen, Patrick F. |
author_facet | van Rheenen, Patrick F. |
author_sort | van Rheenen, Patrick F. |
collection | PubMed |
description | PURPOSE OF REVIEW: Liver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental finding of abnormal liver tests are investigated in an appropriate and timely manner. RECENT FINDINGS: The most prevalent cause of liver test elevations in paediatric IBD is immune-related liver disease, including primary sclerosing cholangitis, autoimmune sclerosing cholangitis, and autoimmune hepatitis. Although less common, drugs used in the treatment of IBD can also cause liver injury. The diagnosis of drug-induced liver injury relies largely on excluding other causes of liver injury, such as viral hepatitis, nonalcoholic fatty liver disease, and biliary and vascular complications. SUMMARY: This review highlights an avenue to a step-wise approach for investigating children with IBD and silent liver test elevations. Central to the timing of diagnostic actions is grading the severity of liver test elevations. |
format | Online Article Text |
id | pubmed-8452316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-84523162021-09-28 Managing abnormal liver tests in children with inflammatory bowel disease van Rheenen, Patrick F. Curr Opin Pediatr GASTROENTEROLOGY AND NUTRITION: Edited by Bradley Barth PURPOSE OF REVIEW: Liver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental finding of abnormal liver tests are investigated in an appropriate and timely manner. RECENT FINDINGS: The most prevalent cause of liver test elevations in paediatric IBD is immune-related liver disease, including primary sclerosing cholangitis, autoimmune sclerosing cholangitis, and autoimmune hepatitis. Although less common, drugs used in the treatment of IBD can also cause liver injury. The diagnosis of drug-induced liver injury relies largely on excluding other causes of liver injury, such as viral hepatitis, nonalcoholic fatty liver disease, and biliary and vascular complications. SUMMARY: This review highlights an avenue to a step-wise approach for investigating children with IBD and silent liver test elevations. Central to the timing of diagnostic actions is grading the severity of liver test elevations. Lippincott Williams & Wilkins 2021-10 2021-07-12 /pmc/articles/PMC8452316/ /pubmed/34261897 http://dx.doi.org/10.1097/MOP.0000000000001045 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | GASTROENTEROLOGY AND NUTRITION: Edited by Bradley Barth van Rheenen, Patrick F. Managing abnormal liver tests in children with inflammatory bowel disease |
title | Managing abnormal liver tests in children with inflammatory bowel disease |
title_full | Managing abnormal liver tests in children with inflammatory bowel disease |
title_fullStr | Managing abnormal liver tests in children with inflammatory bowel disease |
title_full_unstemmed | Managing abnormal liver tests in children with inflammatory bowel disease |
title_short | Managing abnormal liver tests in children with inflammatory bowel disease |
title_sort | managing abnormal liver tests in children with inflammatory bowel disease |
topic | GASTROENTEROLOGY AND NUTRITION: Edited by Bradley Barth |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452316/ https://www.ncbi.nlm.nih.gov/pubmed/34261897 http://dx.doi.org/10.1097/MOP.0000000000001045 |
work_keys_str_mv | AT vanrheenenpatrickf managingabnormallivertestsinchildrenwithinflammatoryboweldisease |